Src inhibits adriamycin-induced senescence and G2 checkpoint arrest by blocking the induction of p21waf1

Cancer Research

Volumn 65, Issue 19, 2005, Pages 8927-8935

  Vigneron, Arnaud ^a   Roninson, Igor B ^b   Gamelin, Erick ^a   Coqueret, Olivier ^a  

^a INSERM   (France)

^b ORDWAY RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1; DOXORUBICIN;

APOPTOSIS; ARTICLE; CANCER CELL; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL DEATH; CELL PROLIFERATION; CONTROLLED STUDY; DNA CONTENT; GENE EXPRESSION; HUMAN; HUMAN CELL; MITOSIS; ONCOGENE C MYC; ONCOGENE SRC; PRIORITY JOURNAL; TETRAPLOIDY;

ANTIBIOTICS, ANTINEOPLASTIC; CELL AGING; CELL LINE, TUMOR; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DNA-BINDING PROTEINS; DOWN-REGULATION; DOXORUBICIN; DRUG RESISTANCE, NEOPLASM; FIBROSARCOMA; G2 PHASE; HUMANS; MITOSIS; POLYPLOIDY; PROMOTER REGIONS (GENETICS); PROTO-ONCOGENE PROTEINS C-MYC; SRC-FAMILY KINASES; STAT3 TRANSCRIPTION FACTOR; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 25444486937     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-05-0461     Document Type: Article

References (35)

1. Shay JW, Roninson IB. Hallmarks of senescence in carcinogenesis and cancer therapy. Oncogene 2004;23:2919-33.
2. Brown JM, Wilson G. Apoptosis genes and resistance to cancer therapy: what does the experimental and clinical data tell us? Cancer Biol Ther 2003;2:477-90.
3. Waldman T, Lengauer C, Kinzler KW, Vogelstein B. Uncoupling of S phase and mitosis induced by anticancer agents in cells lacking p21. Nature 1996;381:713-6.
4. Chang BD, Xuan Y, Broude EV, et al. Role of p53 and p21waf1/cip1 in senescence-like terminal proliferation arrest induced in human tumor cells by chemotherapeutic drugs. Oncogene 1999;18:4808-18.
5. 1 arrest in resulting tetraploid cells. Cancer Res 2001;61:7660-8.
6. 2 and spindle assembly checkpoint adaptation, and tetraploidy arrest: implications for intrinsic and chemically induced genomic instability. Mutat Res 2003;532:245-53.
7. Gudkov AV, Komarova EA. The role of p53 in determining sensitivity to radiotherapy. Nat Rev Cancer 2003;3:117-29.
8. Roman-Gomez J, Castillejo JA, Jimenez A, et al. 5′ CpG island hypermethylation is associated with transcriptional silencing of the p21(CIP1/WAF1/SDI1) gene and confers poor prognosis in acute lymphoblastic leukemia. Blood 2002;99:2291-6.
9. Allan LA, Duhig T, Read M, Fried M. The p21(WAF1/CIP1) promoter is methylated in Rat-1 cells: stable restoration of p53-dependent p21(WAF1/CIP1) expression after transaction of a genomic clone containing the p21(WAF1/CIP1) gene. Mol Cell Biol 2000;20:1291-8.
10. Zhou BP, Liao Y, Xia W, Spohn B, Lee MH, Hung MC. Cytoplasmic localization of p21Cip1/WAF1 by Akt-induced phosphorylation in HER-2/neu-overexpressing cells. Nat Cell Biol 2001;3:245-52.
11. Westbrook TF, Nguyen DX, Thrash BR, McCance DJ. E7 abolishes Raf-induced arrest via mislocalization of p21(Cip1). Mol Cell Biol 2002;22:7041-52.
12. Slupianek A, Schmutte C, Tombline G, et al. BCR/ABL regulates mammalian RecA homologs, resulting in drug resistance. Mol Cell 2001;8:795-806.
13. Johnson D, Agochiya M, Samejima K, Earnshaw W, Frame M, Wyke J. Regulation of both apoptosis and cell survival by the v-Src oncoprotein. Cell Death Differ 2000;7:685-96.
14. Pellegata NS, Antoniono RJ, Redpath JL, Stanbridge EJ. DNA damage and p53-mediated cell cycle arrest: a reevaluation. Proc Natl Acad Sci U S A 1996;93:15209-14.
15. Chang BD, Broude EV, Dokmanovic M, et al. A senescence-like phenotype distinguishes tumor cells that undergo terminal proliferation arrest after exposure to anticancer agents. Cancer Res 1999;59:3761-7.
16. Chang BD, Watanabe K, Broude EV, et al. Effects of p21Waf1/Cip1/Sdi1 on cellular gene expression: implications for carcinogenesis, senescence, and age-related diseases. Proc Natl Acad Sci U S A 2000;97:4291-6.
17. Bienvenu F, Gascan H, Coqueret O. Cyclin D1 represses STAT3 activation through a Cdk4-independent mechanism. J Biol Chem 2001;276:16840-7.
18. Bromberg JF, Horvath CM, Besser D, Lathem WW, Darnell JEJ. Stat3 activation is required for cellular transformation by v-src. Mol Cell Biol 1998;18:2553-8.
19. Bowman T, Broome MA, Sinibaldi D, et al. Stat3-mediated Myc expression is required for Src transformation and PDGF-induced mitogenesis. Proc Natl Acad Sci U S A 2001;98:7319-24.
20. McKenna WG, Weiss MC, Endlich B, et al. Synergistic effect of the v-myc oncogene with H-ras on radioresistance. Cancer Res 1990;50:97-102.
21. Castedo M, Perfettini JL, Roumier T, et al. Mitotic catastrophe constitutes a special case of apoptosis whose suppression entails aneuploidy. Oncogene 2004;23:4362-70.
22. Seoane J, Le HV Massague J. Myc suppression of the p21(Cip1) Cdk inhibitor influences the outcome of the p53 response to DNA damage. Nature 2002;419:729-34.
23. Herold S, Wanzel M, Beuger V et al. Negative regulation of the mammalian UV response by Myc through association with Miz-1. Mol Cell 2002;10:509-21.
24. Cartel AL, Ye X, Goufman E, et al. Myc represses the p21(WAF1/CIP1) promoter and interacts with Sp1/Sp3. Proc Natl Acad Sci U S A 2001;98:4510-5. Epub 2001 Mar 27.
25. Facchini LM, Chen S, Marhin WW, Lear JN, Penn LZ. The Myc negative autoregulation mechanism requires Myc-Max association and involves the c-myc P2 minimal promoter. Mol Cell Biol 1997;17:100-14.
26. Coqueret O, Gascan H. Functional interaction of STATS transcription factor with the cell cycle inhibitor p21WAF1/CIP1/SDI1. J Biol Chem 2000;275:18794-800.
27. Johnstone RW, Ruefli AA, Lowe SW. Apoptosis: a link between cancer genetics and chemotherapy. Cell 2002;108:153-64.
28. Lee S, Schmitt CA. Chemotherapy response and resistance. Curr Opin Genet Dev 2003;13:90-6.
29. Giraud S, Bienvenu F, Avril S, Gascan H, Heery DM, Coqueret O. Functional interaction of STAT3 transcription factor with the coactivator NcoA/SRC1a. J Biol Chem 2002;277:8004-11.
30. Giraud S, Huristone A, Avril S, Coqueret O. Implication of BRG1 and cdk9 in the STAT3-mediated activation of the p21waf1 gens. Oncogene 2004;23:7391-8.
31. Barré B, Avril S, Coqueret O. Opposite regulation of myc and p21waf1 transcription by STAT3 proteins. J Biol Chem 2003;278:2990-6.
32. Perkins ND. Not just a CDK inhibitor: regulation of transcription by p21(WAF1/CIP1/SDI1). Cell Cycle 2002;1:39-41.
33. Yu CL, Meyer DJ, Campbell GS, et al. Enhanced DNA-binding activity of a Stat3-related protein in cells transformed by the Src oncoprotein. Science 1995;269:81-3.
34. Turkson J, Bowman T, Garcia R, Caldenhoven E, De Groot RP, Jove R. Stat3 activation by Src induces specific gene regulation and is required for cell transformation. Mol Cell Biol 1998;18:2545-52.
35. Florenes VA, Lu C, Bhattacharya N, et al. Interleukin-6 dependent induction of the cyclin dependent kinase inhibitor p21WAF1/CIP1 is lost during progression of human malignant melanoma. Oncogene 1999;18:1023-32.